Severe acute hepatitis A associated with acute pure red cell aplasia

Journal of Gastroenterology

Volumn 31, Issue 4, 1996, Pages 612-617

  Tomida, Shinji ^a   Matsuzaki, Yasushi ^a   Nishi, Masaaki ^a   Ikegami, Tadashi ^a   Chiba, Toshiya ^a   Abei, Masato ^a   Tanaka, Naomi ^a   Osuga, Toshiaki ^a   Sato, Yuji ^a   Abe, Tsukasa ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Hepatitis A; Prostaglandin E1; Pure red cell aplasia

Indexed keywords

AMINOTRANSFERASE; BILIRUBIN; GLUCAGON; HEPATITIS A ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INSULIN; PROSTAGLANDIN E2;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASCITES; BILIRUBIN BLOOD LEVEL; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; DISORIENTATION; DROWSINESS; ELECTROENCEPHALOGRAM; ERYTHROCYTE LIFESPAN; HEPATITIS A; HEPATOMEGALY; HUMAN; JAUNDICE; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; PROTHROMBIN TIME; PURE RED CELL ANEMIA;

EID: 0029803363     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02355068     Document Type: Article

References (26)

1. Tanikawa H. Clinical aspects of hepatitis A. Proceedings of 12th Inuyama symposium, Aichi, Japan, Aug 1982. Tokyo: Chugai igakusha, 1982; 53.
2. Tomiyama J, Kudou H, Adachi Y, et al. A case of pure red cell aplasia after hepatitis A. Jpn J Clin Hematol 1987;28:2187-2192.
3. Sugihara M, Murao K, Kakiuchi T, et al. A case in which complication of transient pure red cell aplasia was suspected in the course of acute hepatitis A (abstract). J Jpn Society Intern Med 1987;76:158-159.
4. Fujisaki J, Suga K, Ozaki I, et al. A case which showed marked anemia considered as pure red cell aplasia complicating acute hepatitis A (abstract). J Jpn Society Intern Med 1987;76:131-132.
5. Gundersen SG, Bjoerneklett A, Bruun JN. Severe erhthroblastopenia and hemolytic anemia during a hepatitis A infection. Scand J Infect Dis 1989;21:225-228.
6. Touri R, Nishimura H, Nakamura K, et al. A case of acute hepatitis A complicating acute pure red cell aplasia. J Jpn Society Intern Med 1990;79:111-112.
7. Tomonari A, Hirai K, Aoki H, et al. Pure red cell aplasia and pseudo thrombocytopenia associated with hepatitis A (in Japanese with English abstract). Jpn J Clin Hematol 1991;32:147-151.
8. Fujioka H, Hamaguchi K, Ogasawara M, et al. A case of acute hepatitis A complicating acute pure red cell aplasia (in Japanese with English abstract). Acta Hepatol Jap 1991;32:650-655.
9. Abe K, Utoh H, Yamamoto Y, et al. A case of acute hepatitis type A showing simultaneous occurrence of pure red cell aplasia and hemolytic anemia, (in Japanese) Jpn J Gastroenterol 1991;88: 1500-1503.
10. Sears DA, George JN, Gold MS. Transient red blood cell aplasia in association with viral hepatitis. Arch Intern Med 1975; 135:1585-1589.
11. Pezzimenti JF, Lindenbaum J. Megaloblastic anemia associated with erythroid hypoplasia. Am J Med 1972;53:748-754.
12. Wilson HA, McLaren GD, Dworken HJ, et al. Transient pure red cell aplasia: Cell-mediated suppression of erythropoiesis associated with hepatitis. Ann Int Med 1980;92:196-198.
13. Margolis HS, Naiman OV. Identification of virus components in circulating immune complex isolated during hepatitis A virus infection. Hepatology 1990;11:31-37.
14. Canalese J, Wyke RJ, Vergani D, et al. Circulating immune complexes in patients with fulminant hepatic failure. Gut 1981;22:845-848.
15. Almeida JD, Waterson AP. Immune complexes in hepatitis. Lancet: 1969;8:983-988.
16. Livio C, Mario A. Fulminant hepatic failure. Clinical features, etiology, epidemiology, and current management. Dig Dis Sci 1991;36:775-779.
17. Robert A. Cytoprotection of prostaglandins. Gastroenterology 1979;77:761-767.
18. Stachura J, Tarnawski A, Ivey KJ, et al. Prostaglandin protection of carbon tetrachloride-induced liver cell necrosis in the rat. Gastroenterology 1981;81:211-217.
19. 2 partially prevents necrosis due to aflatoxin in rats. Gastroenterology 1982;82:1167-1169.
20. 2 protection of rat liver against acute injury by galactosamine, acetaminophen, ethanol and ANIT. Gastroenterology 1981;80: 1349-1356.
21. 2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection. J Clin Invest 1987;80:881-889.
22. 1 in an experimental massive hepatic cell necrosis model. Hepatology 1987;7:1184-1188.
23. Abecassis M, Falk JA, Blendi L, et al. Treatment of fulminant hepatic failure with a continuous infusion of Prostin VR (PGE1) (abstract). Hepatology 1987:7:1104.
24. Morioka H. Regeneration of cirrhotic remnant liver after partial hepatectomy, especially the relationship between insulin receptor and hepatic regeneration (in Japanese). Arch Jpn Chir 1986; 55:403-414.
25. Mizoguchi Y, Kuboi H, Kawada N, et al. Effects of lipo-prostaglandin E, in an experimentally induced acute hepatic failure model. Jpn J Inflammation 1990;2:115-118.
26. Okita K, Matsuda S, Hata K, et al. Clinical use of glucagon and insulin in therapy of fulminant hepatic failure. Gastroenterol Jpn 1979;14:453-457.